Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

CRT 2021: PROTECT IV and Beyond with Rajan Patel, MD

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium. 

Intra-aortic Balloon Pump (IABP) FAQs

This FAQ discusses how IABP works and the role of IABP in Protected PCI and cardiogenic shock.

Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella®

The final results of the physician-led NCSI Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used.

Role of the PA Catheter in Managing Cardiogenic Shock

Complete hemodynamic profiling is associated with lower in-hospital mortality.

Optimal Target MAP in Post-Cardiac Arrest AMI Shock

Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.

SCAI Shock Classification Helps Predict Survival in AMICS

Ivan Hanson, MD, explains the SCAI shock staging system and how it can predict survival in AMI cardiogenic shock.

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

Discussion of a Retrospective Matched-Pair Analysis Comparing Patients in Cardiogenic Shock Treated with Balloon Pump and the Impella® Heart Pump

Seth Bilazarian, MD, discusses the limitations of Schrage, Ibrahim, et al. published in Circulation comparing patients in cardiogenic shock treated with balloon pump and the Impella® heart pump. 

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].